L97 Stock Overview
Provides hair-related healthcare services in China. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Yonghe Medical Group Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$0.086 |
52 Week High | HK$0.28 |
52 Week Low | HK$0.06 |
Beta | 0.38 |
11 Month Change | -10.00% |
3 Month Change | 29.55% |
1 Year Change | -69.89% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -95.60% |
Recent News & Updates
Recent updates
Shareholder Returns
L97 | DE Healthcare | DE Market | |
---|---|---|---|
7D | 6.9% | 0.2% | 0.8% |
1Y | -69.9% | 13.9% | 8.6% |
Return vs Industry: L97 underperformed the German Healthcare industry which returned 17.4% over the past year.
Return vs Market: L97 underperformed the German Market which returned 9.1% over the past year.
Price Volatility
L97 volatility | |
---|---|
L97 Average Weekly Movement | 19.1% |
Healthcare Industry Average Movement | 4.0% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.9% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: L97's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: L97's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | 3,826 | Yu Zhang | www.yonghegroup.cn |
Yonghe Medical Group Co., Ltd. provides hair-related healthcare services in China. The company offers hair transplant, medical hair care, routine hair restoration, and other ancillary services. It also engages provision of hair research and consulting services; and wig business.
Yonghe Medical Group Co., Ltd. Fundamentals Summary
L97 fundamental statistics | |
---|---|
Market cap | €48.47m |
Earnings (TTM) | -€59.80m |
Revenue (TTM) | €244.10m |
0.2x
P/S Ratio-0.8x
P/E RatioIs L97 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
L97 income statement (TTM) | |
---|---|
Revenue | CN¥1.85b |
Cost of Revenue | CN¥790.63m |
Gross Profit | CN¥1.06b |
Other Expenses | CN¥1.51b |
Earnings | -CN¥453.16m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.91 |
Gross Margin | 57.26% |
Net Profit Margin | -24.50% |
Debt/Equity Ratio | 16.5% |
How did L97 perform over the long term?
See historical performance and comparison